Showing 73 to 84 of 171 results
BioNTech's Oncology Push: Cancer Drug Filing Planned, Q1 Loss Reported
BioNTech, experiencing a €415.8 million net loss in Q1 2025, plans to file for U.S. approval of a uterine cancer treatment by year-end, aiming to become a leading oncology company by 2030, with a new CFO starting July 1st, 2025.
BioNTech's Oncology Push: Cancer Drug Filing Planned, Q1 Loss Reported
BioNTech, experiencing a €415.8 million net loss in Q1 2025, plans to file for U.S. approval of a uterine cancer treatment by year-end, aiming to become a leading oncology company by 2030, with a new CFO starting July 1st, 2025.
Progress
36% Bias Score
9/11 Responder Health Program Standstill Denies Life-Saving Treatment
Three 9/11 responders with new cancer diagnoses were denied treatment due to a standstill in the World Trade Center Health Program, caused by staffing cuts, budget shortfalls, and an unresolved administrative issue, jeopardizing their lives and highlighting a critical failure in the system designed ...
9/11 Responder Health Program Standstill Denies Life-Saving Treatment
Three 9/11 responders with new cancer diagnoses were denied treatment due to a standstill in the World Trade Center Health Program, caused by staffing cuts, budget shortfalls, and an unresolved administrative issue, jeopardizing their lives and highlighting a critical failure in the system designed ...
Progress
48% Bias Score
NHS England to Offer Faster Injectable Cancer Immunotherapy to 15,000 Patients Annually
The NHS England will provide up to 15,000 cancer patients annually with injectable nivolumab, a faster, more efficient immunotherapy for 15 cancer types, saving significant treatment time and freeing up hospital resources, at no extra cost to the NHS.
NHS England to Offer Faster Injectable Cancer Immunotherapy to 15,000 Patients Annually
The NHS England will provide up to 15,000 cancer patients annually with injectable nivolumab, a faster, more efficient immunotherapy for 15 cancer types, saving significant treatment time and freeing up hospital resources, at no extra cost to the NHS.
Progress
40% Bias Score
Immunotherapy Eliminates Surgery Need in Some Early-Stage Cancers
A new study in the New England Journal of Medicine shows that dostarlimab immunotherapy eliminated the need for surgery in 82 of 103 patients with early-stage cancers with a specific genetic defect; 49 rectal cancer patients avoided surgery, with 92% remaining cancer-free after two years.
Immunotherapy Eliminates Surgery Need in Some Early-Stage Cancers
A new study in the New England Journal of Medicine shows that dostarlimab immunotherapy eliminated the need for surgery in 82 of 103 patients with early-stage cancers with a specific genetic defect; 49 rectal cancer patients avoided surgery, with 92% remaining cancer-free after two years.
Progress
44% Bias Score
Pembrolizumab Extends Head and Neck Cancer Remission by 30 Months
A global phase III trial involving 714 patients with newly diagnosed head and neck cancer showed that pembrolizumab combined with standard treatment significantly increased disease-free survival to 60 months compared to 30 months for standard treatment alone.
Pembrolizumab Extends Head and Neck Cancer Remission by 30 Months
A global phase III trial involving 714 patients with newly diagnosed head and neck cancer showed that pembrolizumab combined with standard treatment significantly increased disease-free survival to 60 months compared to 30 months for standard treatment alone.
Progress
40% Bias Score
Keytruda's $30 Billion Success: Revolutionizing Cancer Treatment
Keytruda, Merck's immunotherapy drug, generated nearly $30 billion in 2024 sales, marking a paradigm shift in cancer treatment since its 2014 launch, building upon research dating back to the late 19th century.
Keytruda's $30 Billion Success: Revolutionizing Cancer Treatment
Keytruda, Merck's immunotherapy drug, generated nearly $30 billion in 2024 sales, marking a paradigm shift in cancer treatment since its 2014 launch, building upon research dating back to the late 19th century.
Progress
48% Bias Score
UK Woman Receives Pioneering Keyhole Breast Reconstruction
A 56-year-old British woman became the first in the UK to receive a new, less invasive keyhole breast reconstruction surgery, recovering in only one to two days with minimal pain, marking a significant advancement in breast cancer treatment.
UK Woman Receives Pioneering Keyhole Breast Reconstruction
A 56-year-old British woman became the first in the UK to receive a new, less invasive keyhole breast reconstruction surgery, recovering in only one to two days with minimal pain, marking a significant advancement in breast cancer treatment.
Progress
12% Bias Score
Childhood Cancer Battle: Family's Perseverance and the Power of Charity
A 14-year-old boy from Varna, Southern Urals, battled stage three non-Hodgkin's B-cell lymphoma, undergoing extensive treatment and overcoming significant financial hurdles with the help of various charitable organizations; he is now studying to become a doctor.
Childhood Cancer Battle: Family's Perseverance and the Power of Charity
A 14-year-old boy from Varna, Southern Urals, battled stage three non-Hodgkin's B-cell lymphoma, undergoing extensive treatment and overcoming significant financial hurdles with the help of various charitable organizations; he is now studying to become a doctor.
Progress
40% Bias Score
NHS England Offers Injectable Cancer Immunotherapy
NHS England becomes the first in Europe to offer injectable nivolumab, an immunotherapy, to treat up to 15,000 cancer patients annually, saving significant time compared to intravenous infusions and improving patient access.
NHS England Offers Injectable Cancer Immunotherapy
NHS England becomes the first in Europe to offer injectable nivolumab, an immunotherapy, to treat up to 15,000 cancer patients annually, saving significant time compared to intravenous infusions and improving patient access.
Progress
40% Bias Score
Immunotherapy Shows Promise in Treating MMR-deficient Solid Tumors
A clinical trial at Memorial Sloan Kettering Cancer Center showed that an immunotherapy treatment led to complete tumor disappearance in all 49 rectal cancer patients and 65% of other cancer patients with a specific genetic mutation (MMR-deficient), avoiding the need for surgery, radiation, and chem...
Immunotherapy Shows Promise in Treating MMR-deficient Solid Tumors
A clinical trial at Memorial Sloan Kettering Cancer Center showed that an immunotherapy treatment led to complete tumor disappearance in all 49 rectal cancer patients and 65% of other cancer patients with a specific genetic mutation (MMR-deficient), avoiding the need for surgery, radiation, and chem...
Progress
40% Bias Score
Immunotherapy Shows Promise in Treating Mismatch Repair Deficient Cancers
A clinical trial at Memorial Sloan Kettering showed that immunotherapy was highly effective in treating mismatch repair deficient (MMRd) cancers, potentially eliminating the need for surgery, chemotherapy, and radiation for many patients, significantly improving quality of life.
Immunotherapy Shows Promise in Treating Mismatch Repair Deficient Cancers
A clinical trial at Memorial Sloan Kettering showed that immunotherapy was highly effective in treating mismatch repair deficient (MMRd) cancers, potentially eliminating the need for surgery, chemotherapy, and radiation for many patients, significantly improving quality of life.
Progress
44% Bias Score
Eye Test Reveals Large Brain Tumor in Seven-Year-Old Girl
Seven-year-old Esmai from Staffordshire was diagnosed with a large brain tumor after an eye test, highlighting the importance of regular children's eye checks; she is now undergoing radiotherapy and her mother has started a crowdfunding campaign for support.
Eye Test Reveals Large Brain Tumor in Seven-Year-Old Girl
Seven-year-old Esmai from Staffordshire was diagnosed with a large brain tumor after an eye test, highlighting the importance of regular children's eye checks; she is now undergoing radiotherapy and her mother has started a crowdfunding campaign for support.
Progress
28% Bias Score
Showing 73 to 84 of 171 results